MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy

Research output: Contribution to journalArticle

Standard

MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy. / Fritsch, P.; O. Grémy, O.; Hurtgen, Christian; Bérard, P.; Grappin, L.; Poncy, J.L.; Verrezen, Freddy (Peer reviewer).

In: Radiation protection dosimetry, Vol. 144, No. 1-4, 01.03.2011, p. 371-375.

Research output: Contribution to journalArticle

Harvard

Fritsch, P, O. Grémy, O, Hurtgen, C, Bérard, P, Grappin, L, Poncy, JL & Verrezen, F 2011, 'MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy', Radiation protection dosimetry, vol. 144, no. 1-4, pp. 371-375. https://doi.org/10.1093/rpd/ncq429

APA

Fritsch, P., O. Grémy, O., Hurtgen, C., Bérard, P., Grappin, L., Poncy, J. L., & Verrezen, F. (2011). MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy. Radiation protection dosimetry, 144(1-4), 371-375. https://doi.org/10.1093/rpd/ncq429

Vancouver

Fritsch P, O. Grémy O, Hurtgen C, Bérard P, Grappin L, Poncy JL et al. MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy. Radiation protection dosimetry. 2011 Mar 1;144(1-4):371-375. https://doi.org/10.1093/rpd/ncq429

Author

Fritsch, P. ; O. Grémy, O. ; Hurtgen, Christian ; Bérard, P. ; Grappin, L. ; Poncy, J.L. ; Verrezen, Freddy. / MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy. In: Radiation protection dosimetry. 2011 ; Vol. 144, No. 1-4. pp. 371-375.

Bibtex - Download

@article{a36d894a9bf8441a85a3018f7a33867f,
title = "MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy",
abstract = "Abstract models have been developed to describe dissolution of Pu/Am/Cm after internal contamination by inhalation or wound, chelation of actinides by diethylene triamine penta acetic acid (DTPA) in different retention compartments and excretion of actinide–DTPA complexes. After coupling these models with those currently used for dose calculation, the modelling approach was assessed by fitting human data available in IDEAS database. Good fits were obtained for most studied cases, but further experimental studies are needed to validate some modelling hypotheses as well as the range of parameter values. From these first results, radioprotection tools are being developed: MAnagement of DOse Reduction after DTPA therapy.",
keywords = "MADOR: A NEW TOOLTO CALCULATE DECREASE OF EFFECTIVE DOSES IN HUMAN AFTER DTPA THERAPY",
author = "P. Fritsch and {O. Gr{\'e}my}, O. and Christian Hurtgen and P. B{\'e}rard and L. Grappin and J.L. Poncy and Freddy Verrezen",
note = "Score = 10",
year = "2011",
month = "3",
day = "1",
doi = "10.1093/rpd/ncq429",
language = "English",
volume = "144",
pages = "371--375",
journal = "Radioation Protection Dosimitry",
issn = "0144-8420",
publisher = "Oxford University Press",
number = "1-4",

}

RIS - Download

TY - JOUR

T1 - MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy

AU - Fritsch, P.

AU - O. Grémy, O.

AU - Hurtgen, Christian

AU - Bérard, P.

AU - Grappin, L.

AU - Poncy, J.L.

A2 - Verrezen, Freddy

N1 - Score = 10

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Abstract models have been developed to describe dissolution of Pu/Am/Cm after internal contamination by inhalation or wound, chelation of actinides by diethylene triamine penta acetic acid (DTPA) in different retention compartments and excretion of actinide–DTPA complexes. After coupling these models with those currently used for dose calculation, the modelling approach was assessed by fitting human data available in IDEAS database. Good fits were obtained for most studied cases, but further experimental studies are needed to validate some modelling hypotheses as well as the range of parameter values. From these first results, radioprotection tools are being developed: MAnagement of DOse Reduction after DTPA therapy.

AB - Abstract models have been developed to describe dissolution of Pu/Am/Cm after internal contamination by inhalation or wound, chelation of actinides by diethylene triamine penta acetic acid (DTPA) in different retention compartments and excretion of actinide–DTPA complexes. After coupling these models with those currently used for dose calculation, the modelling approach was assessed by fitting human data available in IDEAS database. Good fits were obtained for most studied cases, but further experimental studies are needed to validate some modelling hypotheses as well as the range of parameter values. From these first results, radioprotection tools are being developed: MAnagement of DOse Reduction after DTPA therapy.

KW - MADOR: A NEW TOOLTO CALCULATE DECREASE OF EFFECTIVE DOSES IN HUMAN AFTER DTPA THERAPY

UR - http://ecm.sckcen.be/OTCS/llisapi.dll/open/ezp_117686

UR - http://knowledgecentre.sckcen.be/so2/bibref/8606

U2 - 10.1093/rpd/ncq429

DO - 10.1093/rpd/ncq429

M3 - Article

VL - 144

SP - 371

EP - 375

JO - Radioation Protection Dosimitry

JF - Radioation Protection Dosimitry

SN - 0144-8420

IS - 1-4

ER -

ID: 276454